Log in or Sign up for Free to view tailored content for your specialty!
Bone/Mineral Metabolism News
Peak BMD attainment varies by sex, skeletal site

A cross-sectional analysis of national survey data shows that age at peak bone mineral density attainment varies by sex and skeletal site, with women reaching peak BMD at all sites up to 4 years earlier than men, according to findings published in Bone.
Increased prevalence, reduced survival observed among adults with X-linked hypophosphatemia
Conservative estimates suggest that the prevalence of X-linked hypophosphatemia, or XLH, a rare form of rickets, has more than tripled in the past 25 years in the United Kingdom, with researchers noting a concerning reduction in survival among patients with the disease.
Log in or Sign up for Free to view tailored content for your specialty!
Romosozumab increases bone density across varying levels of renal function

ATLANTA — Romosozumab increases bone mineral density among patients with osteoporosis across different levels of renal function, according to a presenter at ACR/ARP 2019.
Smoking, alcohol use raise fracture risk for young men

Young men who reported smoking at least 21 cigarettes per day or drinking heavily were up to 70% more likely to experience a fracture in middle-age when compared with nonsmokers or men who reported moderate alcohol consumption, according to findings published in the Journal of Bone and Mineral Research.
Vitamin D, fish oil fail to reduce first HF hospitalization risk

PHILADELPHIA — Interventions with vitamin D or omega-3 failed to reduce rates of first heart failure hospitalization in a large cohort of healthy adults, although researchers observed a benefit for recurrent HF hospitalization with fish oil supplementation, according to findings from an ancillary study of the VITAL trial presented at the American Heart Association Scientific Sessions.
Levothyroxine neutral for bone health in subclinical hypothyroidism

Older adults with subclinical hypothyroidism assigned 1 year of levothyroxine therapy experienced no adverse changes in any bone parameters compared with similar adults assigned placebo, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Denosumab discontinuation increases risk for major osteoporotic, vertebral fractures

Older adults who discontinue denosumab are at greater risk for major osteoporotic fractures and multiple vertebral fractures than those who persist with treatment, according to findings from a real-world database analysis published in Bone.
Great Debate tackles first-line anabolic therapy for glucocorticoid-induced osteoporosis

ATLANTA — The 2019 iteration of the ACR/ARP Great Debate tackled the issue of whether anabolic therapies are appropriate for patients with glucocorticoid-induced osteoporosis.
Short sleep may worsen bone health for women

Postmenopausal women who report sleeping less than 5 hours per night are more likely to develop low bone mineral density at all major sites and are at increased risk for osteoporosis at the hip and spine, according to findings published in the Journal of Bone and Mineral Research.
Low-protein rice, low-phosphorus whey may improve hyperphosphatemia

WASHINGTON — For patients on hemodialysis who eat rice as a main source of calories, low-protein rice plus low-phosphorus whey can reduce serum phosphorus and improve serum albumin, according to study results presented at ASN Kidney Week.
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read